Verisk (VRSK) Form 144 Discloses 5,420-Share Sale via Merrill Lynch

Rhea-AI Filing Summary

Verisk Analytics (VRSK) Form 144 notifies proposed sale of 5,420 shares of common stock through Merrill Lynch with an aggregate market value of $1,436,300.00 and lists total shares outstanding as 139,714,971. The filing shows the securities were acquired via equity compensation: 652 shares vested 01/10/2025, 136 shares vested 01/15/2025, and 4,632 shares from a broker-assisted cashless exercise on 09/03/2025. The notice also discloses three prior sales by Nicholas Daffan in June, July, and August 2025, each of roughly 5,419–5,420 shares with gross proceeds reported. The proposed sale is scheduled for 09/03/2025.

Positive

• Timely disclosure of proposed sale under Rule 144 enhances market transparency
• Acquisition details provided (vesting dates and exercise method) clarify the origin of the shares
• Broker identified (Merrill Lynch), indicating use of a regulated intermediary for the transaction

Negative

• Insider sales reported in three consecutive months (June, July, August 2025), which may attract investor attention despite no new company information disclosed
• Aggregate market value shown for the proposed sale ($1,436,300.00) is non-trivial relative to an individual holder

Insights

Securities Analyst

Routine insider sale from recent equity awards; disclosure improves transparency but is not a material corporate event.

The Form 144 documents a planned sale of 5,420 shares by an insider using Merrill Lynch as broker and shows the shares originated largely from recent equity compensation vesting and a cashless option exercise. The filing also lists three similar sales in the prior three months by the same individual with published gross proceeds, indicating ongoing personal liquidity transactions rather than a change in company operations or guidance. For investors, this is a compliance and disclosure matter rather than new operational information.

Corporate Governance Expert

Disclosure aligns with Rule 144 requirements; shows insider followed brokered sale procedures and attested to lack of undisclosed material information.

The notice includes the standard attestation that the seller does not possess undisclosed material information and records acquisition details (vesting dates and exercise). Use of a broker-assisted cashless exercise and repeated monthly sales are documented. From a governance perspective, timely Form 144 filings support market transparency and compliance with resale rules, with no governance actions or policy changes reported in this filing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 225 Liberty St Floor 37 New York NY 10281	5420	1436300.00	139714971	09/03/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/10/2025	Vesting of performance share award	Verisk Analytics, Inc.			652	01/10/2025	Granted as part of issuer equity compensation plan
Common Stock	01/15/2025	Vesting of restricted share award	Verisk Analytics, Inc.			136	01/15/2025	Granted as part of issuer equity compensation plan
Common Stock	09/03/2025	Exercise of employee stock options	Verisk Analytics, Inc.			4632	09/03/2025	Broker assisted cashless exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Nicholas Daffan 545 WASHINGTON BOULEVARD JERSEY CITY NJ 07310-1686	Common Stock	08/04/2025	5420	1474402.60
Nicholas Daffan 545 WASHINGTON BOULEVARD JERSEY CITY NJ 07310-1686	Common Stock	07/03/2025	5419	1630360.34
Nicholas Daffan 545 WASHINGTON BOULEVARD JERSEY CITY NJ 07310-1686	Common Stock	06/04/2025	5419	1723783.90

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for VRSK disclose?

The Form 144 discloses a proposed sale of 5,420 shares of Verisk Analytics common stock scheduled for 09/03/2025 with an aggregate market value of $1,436,300.00.

Who is the seller named in the filing for VRSK?

Prior sales in the filing are attributed to Nicholas Daffan at the address listed; the proposed sale will be brokered by Merrill Lynch.

How were the shares acquired that are being sold under Rule 144?

The filing shows shares were acquired via equity compensation: 652 shares vested on 01/10/2025, 136 vested on 01/15/2025, and 4,632 resulted from a broker-assisted cashless option exercise on 09/03/2025.

What prior sales does the Form 144 disclose in the past three months?

The filing lists three sales by Nicholas Daffan: 06/04/2025 (5,419 shares, gross proceeds $1,723,783.90), 07/03/2025 (5,419 shares, $1,630,360.34), and 08/04/2025 (5,420 shares, $1,474,402.60).

Who is the broker handling the proposed sale on the Form 144?

The broker is listed as Merrill Lynch at 225 Liberty St Floor 37, New York, NY 10281, and the exchange named is NASDAQ.